VRUS update for forward long term view - HOLDING here and

New Post Public Reply Private Reply Replies (0) Message Board
NotRichYet2
1,179
VRUS update for forward long term view - HOLDING here and ADDING

1.) VRUS won't/isn't moving on news anymore.


2.) We are being penalized b/c we are legit OTC company.

I feel like everyone missed the signal through all the noise in the last week while we sold off to the .014ish area. On monday, VRUS releases a monster PR that shows a detailed 5 year plan for a path to 400M in revenue with a 20% net margin -- that's 100 millys in profit if you don't have a calculator out! Not to mention on this path to 400M in revenue, it required ZERO dilution and its performance based, meaning US shareholders took no collateral damage or risk from this deal. If they perform VRUS is generating half-a-billion in revenue, if they don't or they don't perform up to the business plan then we have lost nothing.

So, lets disregard any multiplier at this point and go straight off the business plan - without any adjustments to the share structure this deal alone puts us trading in the 20 cent range. Now, you factor in the french fry deal, and BLF and we are firmly at the half billion range and possibly at the 3/4 billion range....so 30-35 cents???

Okay now i'm going to hit yall with a little info from Mark in an email i sent him on Tuesday:

"Nutribrands is part branded product company, part distributor, but it is Brazil based. Most of the product is sourced in the U.S. They needed funds to really expand, so Verus's new revolver can be used to kick up their growth rate. In particular, the Vivamil energy shot (which is the leading five-hour-energy type product in Brazil) has tremendous potential. This was just one of multiple deals in work. As mentioned in the last call, Verus had more than one late stage M&A deal in play."

So key take aways here:

1.) Nutribrand just needed VRUS to provide capital to ramp up sales - meaning they probably already have contracts, agreements, and demand -- simply put, the revenues are coming.

2.)Vivamil = 5 hour energy for Brazil. Let that sink in. Every gas station, every grocery store. I will also provide this snippet of research:

"Brazil’s energy drink market was valued at USD 2.23 billion in 2017 and the market is expected to register a CAGR of 9.4% during the forecast period, (2018-2023)"

We capture 1% that's $23M a year.....

They also produce "Stacker 2" -- which you have seen "Stacker" in gas stations in the US right next to the cash register.

Last, but not least, Garnock is involved in a Nutraceutical business (Disruption Labs) that we have all wondered 24/7 how it ties into VRUS....THEN... lol...VRUS goes and negotiates a deal for a controlling interest in a INTERNATIONAL NUTRACEUTICAL business and people have spent the past week worried.....??? This was the deal we have been waiting months and months for and NO ONE IS FOCUSED ON IT!!!! They are worried about MONAKER.

3.) Most of the product is sourced in the US. To me this is huge from Mark -- if Nutribrands sources their products from the US that means they are produced in manufacturing facilities that meet ISO, FDA, etc etc requirements. Meaning - VRUS can help grow this partnership and help this Brazilian company expand further into the US market b/c the products ALREADY meet the requirements to be sold here -- inspection, testing etc. It would be more difficult if they were produced in a South American factory...trying to get into the US.

4.) "VRUS had more than 1 late stage acquisition in play" -- to me, he's basically saying, stay tuned...there is more to come.... is there anything else that needs to be said????

Okay --- Now take all of that goodness and lets talk about what Coachshot was saying. VRUS is not moving on news anymore - its not because the news isn't amazing! I just spent the first part of this post showing you that VRUS -in the coming years- has already set themselves up to generating a half a billion to a billion dollars of revenue. VRUS is going to move on results - which are quarter over quarter execution. In this way, we are being penalized for not being some hyped company...the SP will grow exponentially as quarterly results and 10Ks are filed.

I guess the point of all of this is that here we sit at .015, but Anshu has already provided a detailed and basically RISK FREE path to a billion dollar company --- said in a different way -- the PRs that have already come out put this trading at .30-.45...so you have free money staring you in the face.

Then the last part -- its all about execution. What I would say is that do you think Anshu has crafted these PERFORMANCE BASED deals without giving away equity (dilution) for VRUS not to execute?? All the parties involved are incentivized to do just that -- execute. If they don't execute and succeed then they don't get PAID! That is a huge bargaining chip and its what the best companies do correctly!

Last part I'll address is the Monaker part. Okay Monaker is selling their shares b/c they need cash flow b/c the want to launch a product. Great, they have 100m shares. Ummmm.....GARNOCK OWNS 1 BILLION SHARES. Okay, go back...read that again. You are worried about a failing company liquidating 1/10th of Garnocks position???? Let me try this a different way....YOU DON'T BUY 1 BILLION SHARES TO SELL THEM at .01, .015, .02 ....there is something else going on here and its real. If you dont think its real or need a reminder read the above post again, go read all the DD again...see if it all points in the same direction.

My business school statistics prof would always say - "there are no coincidences in life." His example, bumping into someone you know at a store -- people are like its a coincidence! When you do the math the actual probability is like 25% or something...so no coincidence in life.

Okay so do the probability here of a very successful dude owning 1 Billion shares in a company that is being laid out and crafted to be 100% legit, with big board fundamentals, extremely successful leaders, and big board resources, taking all the proper steps to facilitate business (LOCs, Credit Insurance etc)....acquiring companies via zero dilution, with performance based-sound business plans, with turn-key products, in the largest growing markets in the world (Middle East, Brazil, Ice Cream, CBD, Nutraceuticals).....NONE of this is a coincidence.

The shares you are looking at right now seem to be worth .015 - in all actuality they are already worth 20x-30x that if you are -like Mark said- able to read between the lines....or just read the damn lines themselves.

Accumulate everything you can within reason based on your own financial status and sit patiently for the quarterly filings - like Coachshot said - because this is a real company and they only reason we arent trading where we should be is b/c the OTC is a hype machine. However, the fact remains, this company and all of the "COINCIDENCES" will make it to the big boards based on fundamental in time......JUST SIT BACK FOR THE RIDE.

1.) VRUS won't/isn't moving on news anymore.


2.) We are being penalized b/c we are legit OTC company.

I feel like everyone missed the signal through all the noise in the last week while we sold off to the .014ish area. On monday, VRUS releases a monster PR that shows a detailed 5 year plan for a path to 400M in revenue with a 20% net margin -- that's 100 millys in profit if you don't have a calculator out! Not to mention on this path to 400M in revenue, it required ZERO dilution and its performance based, meaning US shareholders took no collateral damage or risk from this deal. If they perform VRUS is generating half-a-billion in revenue, if they don't or they don't perform up to the business plan then we have lost nothing.

So, lets disregard any multiplier at this point and go straight off the business plan - without any adjustments to the share structure this deal alone puts us trading in the 20 cent range. Now, you factor in the french fry deal, and BLF and we are firmly at the half billion range and possibly at the 3/4 billion range....so 30-35 cents???

Okay now i'm going to hit yall with a little info from Mark in an email i sent him on Tuesday:

"Nutribrands is part branded product company, part distributor, but it is Brazil based. Most of the product is sourced in the U.S. They needed funds to really expand, so Verus's new revolver can be used to kick up their growth rate. In particular, the Vivamil energy shot (which is the leading five-hour-energy type product in Brazil) has tremendous potential. This was just one of multiple deals in work. As mentioned in the last call, Verus had more than one late stage M&A deal in play."

So key take aways here:

1.) Nutribrand just needed VRUS to provide capital to ramp up sales - meaning they probably already have contracts, agreements, and demand -- simply put, the revenues are coming.

2.)Vivamil = 5 hour energy for Brazil. Let that sink in. Every gas station, every grocery store. I will also provide this snippet of research:

"Brazil’s energy drink market was valued at USD 2.23 billion in 2017 and the market is expected to register a CAGR of 9.4% during the forecast period, (2018-2023)"

We capture 1% that's $23M a year.....

They also produce "Stacker 2" -- which you have seen "Stacker" in gas stations in the US right next to the cash register.

Last, but not least, Garnock is involved in a Nutraceutical business (Disruption Labs) that we have all wondered 24/7 how it ties into VRUS....THEN... lol...VRUS goes and negotiates a deal for a controlling interest in a INTERNATIONAL NUTRACEUTICAL business and people have spent the past week worried.....??? This was the deal we have been waiting months and months for and NO ONE IS FOCUSED ON IT!!!! They are worried about MONAKER.

3.) Most of the product is sourced in the US. To me this is huge from Mark -- if Nutribrands sources their products from the US that means they are produced in manufacturing facilities that meet ISO, FDA, etc etc requirements. Meaning - VRUS can help grow this partnership and help this Brazilian company expand further into the US market b/c the products ALREADY meet the requirements to be sold here -- inspection, testing etc. It would be more difficult if they were produced in a South American factory...trying to get into the US.

4.) "VRUS had more than 1 late stage acquisition in play" -- to me, he's basically saying, stay tuned...there is more to come.... is there anything else that needs to be said????

Okay --- Now take all of that goodness and lets talk about what Coachshot was saying. VRUS is not moving on news anymore - its not because the news isn't amazing! I just spent the first part of this post showing you that VRUS -in the coming years- has already set themselves up to generating a half a billion to a billion dollars of revenue. VRUS is going to move on results - which are quarter over quarter execution. In this way, we are being penalized for not being some hyped company...the SP will grow exponentially as quarterly results and 10Ks are filed.

I guess the point of all of this is that here we sit at .015, but Anshu has already provided a detailed and basically RISK FREE path to a billion dollar company --- said in a different way -- the PRs that have already come out put this trading at .30-.45...so you have free money staring you in the face.

Then the last part -- its all about execution. What I would say is that do you think Anshu has crafted these PERFORMANCE BASED deals without giving away equity (dilution) for VRUS not to execute?? All the parties involved are incentivized to do just that -- execute. If they don't execute and succeed then they don't get PAID! That is a huge bargaining chip and its what the best companies do correctly!

Last part I'll address is the Monaker part. Okay Monaker is selling their shares b/c they need cash flow b/c the want to launch a product. Great, they have 100m shares. Ummmm.....GARNOCK OWNS 1 BILLION SHARES. Okay, go back...read that again. You are worried about a failing company liquidating 1/10th of Garnocks position???? Let me try this a different way....YOU DON'T BUY 1 BILLION SHARES TO SELL THEM at .01, .015, .02 ....there is something else going on here and its real. If you dont think its real or need a reminder read the above post again, go read all the DD again...see if it all points in the same direction.

My business school statistics prof would always say - "there are no coincidences in life." His example, bumping into someone you know at a store -- people are like its a coincidence! When you do the math the actual probability is like 25% or something...so no coincidence in life.

Okay so do the probability here of a very successful dude owning 1 Billion shares in a company that is being laid out and crafted to be 100% legit, with big board fundamentals, extremely successful leaders, and big board resources, taking all the proper steps to facilitate business (LOCs, Credit Insurance etc)....acquiring companies via zero dilution, with performance based-sound business plans, with turn-key products, in the largest growing markets in the world (Middle East, Brazil, Ice Cream, CBD, Nutraceuticals).....NONE of this is a coincidence.

The shares you are looking at right now seem to be worth .015 - in all actuality they are already worth 20x-30x that if you are -like Mark said- able to read between the lines....or just read the damn lines themselves.

Accumulate everything you can within reason based on your own financial status and sit patiently for the quarterly filings - like Coachshot said - because this is a real company and they only reason we arent trading where we should be is b/c the OTC is a hype machine. However, the fact remains, this company and all of the "COINCIDENCES" will make it to the big boards based on fundamental in time......JUST SIT BACK FOR THE RIDE.

1.) VRUS won't/isn't moving on news anymore.


2.) We are being penalized b/c we are legit OTC company.

I feel like everyone missed the signal through all the noise in the last week while we sold off to the .014ish area. On monday, VRUS releases a monster PR that shows a detailed 5 year plan for a path to 400M in revenue with a 20% net margin -- that's 100 millys in profit if you don't have a calculator out! Not to mention on this path to 400M in revenue, it required ZERO dilution and its performance based, meaning US shareholders took no collateral damage or risk from this deal. If they perform VRUS is generating half-a-billion in revenue, if they don't or they don't perform up to the business plan then we have lost nothing.

So, lets disregard any multiplier at this point and go straight off the business plan - without any adjustments to the share structure this deal alone puts us trading in the 20 cent range. Now, you factor in the french fry deal, and BLF and we are firmly at the half billion range and possibly at the 3/4 billion range....so 30-35 cents???

Okay now i'm going to hit yall with a little info from Mark in an email i sent him on Tuesday:

"Nutribrands is part branded product company, part distributor, but it is Brazil based. Most of the product is sourced in the U.S. They needed funds to really expand, so Verus's new revolver can be used to kick up their growth rate. In particular, the Vivamil energy shot (which is the leading five-hour-energy type product in Brazil) has tremendous potential. This was just one of multiple deals in work. As mentioned in the last call, Verus had more than one late stage M&A deal in play."

So key take aways here:

1.) Nutribrand just needed VRUS to provide capital to ramp up sales - meaning they probably already have contracts, agreements, and demand -- simply put, the revenues are coming.

2.)Vivamil = 5 hour energy for Brazil. Let that sink in. Every gas station, every grocery store. I will also provide this snippet of research:

"Brazil’s energy drink market was valued at USD 2.23 billion in 2017 and the market is expected to register a CAGR of 9.4% during the forecast period, (2018-2023)"

We capture 1% that's $23M a year.....

They also produce "Stacker 2" -- which you have seen "Stacker" in gas stations in the US right next to the cash register.

Last, but not least, Garnock is involved in a Nutraceutical business (Disruption Labs) that we have all wondered 24/7 how it ties into VRUS....THEN... lol...VRUS goes and negotiates a deal for a controlling interest in a INTERNATIONAL NUTRACEUTICAL business and people have spent the past week worried.....??? This was the deal we have been waiting months and months for and NO ONE IS FOCUSED ON IT!!!! They are worried about MONAKER.

3.) Most of the product is sourced in the US. To me this is huge from Mark -- if Nutribrands sources their products from the US that means they are produced in manufacturing facilities that meet ISO, FDA, etc etc requirements. Meaning - VRUS can help grow this partnership and help this Brazilian company expand further into the US market b/c the products ALREADY meet the requirements to be sold here -- inspection, testing etc. It would be more difficult if they were produced in a South American factory...trying to get into the US.

4.) "VRUS had more than 1 late stage acquisition in play" -- to me, he's basically saying, stay tuned...there is more to come.... is there anything else that needs to be said????

Okay --- Now take all of that goodness and lets talk about what Coachshot was saying. VRUS is not moving on news anymore - its not because the news isn't amazing! I just spent the first part of this post showing you that VRUS -in the coming years- has already set themselves up to generating a half a billion to a billion dollars of revenue. VRUS is going to move on results - which are quarter over quarter execution. In this way, we are being penalized for not being some hyped company...the SP will grow exponentially as quarterly results and 10Ks are filed.

I guess the point of all of this is that here we sit at .015, but Anshu has already provided a detailed and basically RISK FREE path to a billion dollar company --- said in a different way -- the PRs that have already come out put this trading at .30-.45...so you have free money staring you in the face.

Then the last part -- its all about execution. What I would say is that do you think Anshu has crafted these PERFORMANCE BASED deals without giving away equity (dilution) for VRUS not to execute?? All the parties involved are incentivized to do just that -- execute. If they don't execute and succeed then they don't get PAID! That is a huge bargaining chip and its what the best companies do correctly!

Last part I'll address is the Monaker part. Okay Monaker is selling their shares b/c they need cash flow b/c the want to launch a product. Great, they have 100m shares. Ummmm.....GARNOCK OWNS 1 BILLION SHARES. Okay, go back...read that again. You are worried about a failing company liquidating 1/10th of Garnocks position???? Let me try this a different way....YOU DON'T BUY 1 BILLION SHARES TO SELL THEM at .01, .015, .02 ....there is something else going on here and its real. If you dont think its real or need a reminder read the above post again, go read all the DD again...see if it all points in the same direction.

My business school statistics prof would always say - "there are no coincidences in life." His example, bumping into someone you know at a store -- people are like its a coincidence! When you do the math the actual probability is like 25% or something...so no coincidence in life.

Okay so do the probability here of a very successful dude owning 1 Billion shares in a company that is being laid out and crafted to be 100% legit, with big board fundamentals, extremely successful leaders, and big board resources, taking all the proper steps to facilitate business (LOCs, Credit Insurance etc)....acquiring companies via zero dilution, with performance based-sound business plans, with turn-key products, in the largest growing markets in the world (Middle East, Brazil, Ice Cream, CBD, Nutraceuticals).....NONE of this is a coincidence.

The shares you are looking at right now seem to be worth .015 - in all actuality they are already worth 20x-30x that if you are -like Mark said- able to read between the lines....or just read the damn lines themselves.

Accumulate everything you can within reason based on your own financial status and sit patiently for the quarterly filings - like Coachshot said - because this is a real company and they only reason we arent trading where we should be is b/c the OTC is a hype machine. However, the fact remains, this company and all of the "COINCIDENCES" will make it to the big boards based on fundamental in time......JUST SIT BACK FOR THE RIDE.

Verus International, Inc. (VRUS) Stock Research Links

VRUS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Indico Breach May Expose Thousands to Identity Theft

Updated Category News Views 4

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Continue Reading
Zepp Health's Q2 2026 Results: Growth Amid Struggles

Updated Category News Views 4

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 8

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 6

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 0

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Volato Group Faces Merger Scrutiny Amid SOAR Deal

Updated Category News Views 2

Unraveling the Volato Merger Drama Boy, the plot thickens with Volato Group, Inc. (SOAR), and it ain’t the first time we’ve seen this kind of shuffle in the market. Now, Volato’s got itself tangled up with Alignment Engine Inc. through a proposed merger. Sounds routine at first; we all know mergers are part of the corporate game. But here's the twist—shareholders...

Continue Reading
Kareem's Lebanese Kitchen: A Culinary Tribute to Maryland

Updated Category News Views 4

Embracing Tradition with a Modern Twist Well, here's to new beginnings wrapped in old flavors, folks. September 1, 2026, marks the arrival of Kareem's Lebanese Kitchen at Rio Lakefront in Gaithersburg, Maryland. It's where the Mediterranean meets the Chesapeake in an unexpected culinary celebration. Chef Rachid Eido's Legacy Third-generation Lebanese Chef Rachid Eido is...

Continue Reading
RealityMine Appoints CPO Amidst Strong Growth Momentum

Updated Category News Views 0

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Continue Reading
Kroger's Strategic Shift: Ibbotson's Bold New Charge

Updated Category News Views 0

Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...

Continue Reading
Innventure Faces Class Action Over Alleged Deception

Updated Category News Views 3

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...

Continue Reading

Top 5 Most Recently Viewed Articles

ABN AMRO Advances Share Buyback Program with Key Updates

Updated Category News Views 207

ABN AMRO's Share Buyback Program Progress Overview ABN AMRO has recently reported significant advancements regarding its EUR 250 million share buyback program that was announced earlier in the month. This initiative aims to bolster shareholders' value and demonstrate the bank's commitment to enhancing its financial position. Transaction Details and Financial Insights...

Continue Reading
Exploring Recent Options Activity in Robinhood Markets Stock

Updated Category News Views 80

What Recent Options Trades Say About Robinhood Markets Investors are leaning bearish on Robinhood Markets, and the options tape shows it. Recent flow highlights how larger traders are setting up, offering a clear read on sentiment without guessing at motives. Breaking Down the Recent Trades In our review of options activity for Robinhood Markets (NASDAQ: HOOD), we counted...

Continue Reading
Neuronetics Enhances Registration Rights for Shareholders

Updated Category News Views 108

Neuronetics Amends Registration Rights Agreement Neuronetics, Inc. (NASDAQ: STIM), a pioneering medical technology firm, has recently made significant changes to its Registration Rights Agreement with Madryn Asset Management LP. This amendment extends the period for Madryn to demand the registration of their acquired shares, increasing the Demand Registration Period from...

Continue Reading
Macy's Sales Performance and Strategic Outlook for the Holidays

Updated Category News Views 168

Insights into Macy's Recent Performance Macy’s Inc (NYSE: M) has recently revealed its sales dynamics, indicating that even during a period of stronger financial results, its stock took a slight dip. Despite a notable improvement in sales, profit, and comparable growth metrics, the market response has been tempered, reflecting complex customer behaviors ahead of the...

Continue Reading
Steward Partners Celebrates Seven Teams in Forbes Rankings

Updated Category News Views 97

Celebrating Steward Partners' Remarkable Forbes Recognition Top honors reflect exceptional service, teamwork, and commitment to excellence Steward Partners, a thriving independent financial services firm known for its employee-owned model, recently celebrated a significant achievement. The firm proudly announced that seven of its partners have been recognized in the...

Continue Reading